Keywords: astrazeneca, seeks, japan, market, share, although, japanese
AstraZeneca seeks 6% Japan market share
Article | 10 December 2007
Although AstraZeneca's share of the Japanese prescription drug market in 2002 was only 2.01%, ranking number 17, "we could boost it to 2.59%, ranking ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
